Clas Sonesson

1.2k total citations
48 papers, 1.0k citations indexed

About

Clas Sonesson is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Clas Sonesson has authored 48 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cellular and Molecular Neuroscience, 18 papers in Molecular Biology and 17 papers in Organic Chemistry. Recurrent topics in Clas Sonesson's work include Neurotransmitter Receptor Influence on Behavior (16 papers), Neuroscience and Neuropharmacology Research (15 papers) and Receptor Mechanisms and Signaling (15 papers). Clas Sonesson is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (16 papers), Neuroscience and Neuropharmacology Research (15 papers) and Receptor Mechanisms and Signaling (15 papers). Clas Sonesson collaborates with scholars based in Sweden, United States and United Kingdom. Clas Sonesson's co-authors include Nicholas Waters, Joakim Tedroff, Fredrik Pettersson, Arvid Carlsson, Peder Svensson, Martin Smith, Anders Hallberg, Kjell Svensson, Lars O. Hansson and Arvid Carlsson and has published in prestigious journals such as Neurology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Clas Sonesson

48 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clas Sonesson Sweden 20 608 440 256 246 89 48 1.0k
Sylvie Perachon France 8 716 1.2× 578 1.3× 116 0.5× 115 0.5× 101 1.1× 10 985
Nora S. Kula United States 24 867 1.4× 658 1.5× 209 0.8× 261 1.1× 110 1.2× 70 1.5k
Christoph A. Seyfried Germany 19 468 0.8× 416 0.9× 102 0.4× 335 1.4× 39 0.4× 41 1.1k
Durk Dijkstra Netherlands 22 865 1.4× 784 1.8× 116 0.5× 328 1.3× 52 0.6× 79 1.5k
Garrick P. Smith Denmark 15 282 0.5× 326 0.7× 155 0.6× 153 0.6× 66 0.7× 23 865
Jean-Louis Péglion France 22 596 1.0× 539 1.2× 51 0.2× 418 1.7× 85 1.0× 38 1.4k
Deborah K. Hyslop United States 12 515 0.8× 324 0.7× 101 0.4× 93 0.4× 106 1.2× 19 900
Tomasz Lenda Poland 21 390 0.6× 370 0.8× 226 0.9× 159 0.6× 32 0.4× 49 915
Andrew Thurkauf United States 23 943 1.6× 998 2.3× 68 0.3× 415 1.7× 73 0.8× 61 1.6k
Hyacinth C. Akunne United States 24 1.0k 1.7× 925 2.1× 69 0.3× 248 1.0× 49 0.6× 49 1.5k

Countries citing papers authored by Clas Sonesson

Since Specialization
Citations

This map shows the geographic impact of Clas Sonesson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clas Sonesson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clas Sonesson more than expected).

Fields of papers citing papers by Clas Sonesson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clas Sonesson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clas Sonesson. The network helps show where Clas Sonesson may publish in the future.

Co-authorship network of co-authors of Clas Sonesson

This figure shows the co-authorship network connecting the top 25 collaborators of Clas Sonesson. A scholar is included among the top collaborators of Clas Sonesson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clas Sonesson. Clas Sonesson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Antonini, Angelo, Padraig O’Suilleabhain, Fabrizio Stocchi, et al.. (2025). Mesdopetam for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease: A Randomized Phase 2b Trial. Movement Disorders Clinical Practice. 12(6). 796–806. 4 indexed citations
2.
Hjorth, Stephan, Nicholas Waters, Joakim Tedroff, et al.. (2020). (3S)‐3‐(2,3‐difluorophenyl)‐3‐methoxypyrrolidine (IRL752) —a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent. Journal of Pharmacology and Experimental Therapeutics. 374(3). 404–419. 4 indexed citations
3.
Waters, Nicholas, Clas Sonesson, Peder Svensson, et al.. (2020). Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease. Journal of Pharmacology and Experimental Therapeutics. 374(1). 113–125. 18 indexed citations
4.
Waters, Nicholas, et al.. (2018). Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington’s Disease. Journal of Huntington s Disease. 7(1). 1–16. 20 indexed citations
5.
Svenningsson, Per, Anders Johansson, Dag Nyholm, et al.. (2018). Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial. npj Parkinson s Disease. 4(1). 35–35. 19 indexed citations
6.
Waters, Nicholas, et al.. (2016). In Vivo Systems Response Profiling and Multivariate Classification of CNS Active Compounds: A Structured Tool for CNS Drug Discovery. ACS Chemical Neuroscience. 8(4). 785–797. 11 indexed citations
7.
Mattsson, Cecilia, et al.. (2013). Structure–activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT6 receptor agonists. European Journal of Medicinal Chemistry. 63. 578–588. 7 indexed citations
8.
Mattsson, C. Mikael, Peder Svensson, & Clas Sonesson. (2013). A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors. European Journal of Medicinal Chemistry. 73. 177–186. 24 indexed citations
9.
Lagerkvist, Sören, et al.. (2010). In vivo pharmacology of the dopaminergic stabilizer pridopidine. European Journal of Pharmacology. 644(1-3). 88–95. 47 indexed citations
10.
Mattsson, Cecilia, Clas Sonesson, Hartmut E. Greiner, et al.. (2005). 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 15(19). 4230–4234. 49 indexed citations
11.
Nilsson, Marie K. L., et al.. (2004). The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(4). 677–685. 27 indexed citations
12.
Andrén, Per E., et al.. (2000). Motor effects of (−)-OSU6162 in primates with unilateral 6-hydroxydopamine lesions. European Journal of Pharmacology. 389(2-3). 193–199. 9 indexed citations
13.
Torstenson, Richard, Per Hartvig, Arvid Carlsson, et al.. (1999). Effects of the substituted (S)-3-phenylpiperidine (−)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains. Neuropharmacology. 38(3). 331–338. 22 indexed citations
14.
15.
Sonesson, Clas, et al.. (1997). Regioselective synthesis of 3-aryl substituted pyrrolidines via palladium catalyzed arylation: pharmacological evaluation for central dopaminergic and serotonergic activity. Bioorganic & Medicinal Chemistry. 3. 241–246. 2 indexed citations
16.
Sonesson, Clas, et al.. (1997). OSU6182 a representative from a unique class of functional modulators of dopaminergic systems. The Society for Neuroscience Abstracts. 23. 531. 3 indexed citations
17.
19.
Clark, David, et al.. (1995). Effects of the dopamine autoreceptor antagonist (−)-DS121 on the discriminative stimulus properties of d-amphetamine and cocaine. European Journal of Pharmacology. 275(1). 67–74. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026